Clinical Trial Update: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of ALIC/NAcc-DBS for treatment-refractory obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Obsessive-Compulsive Disorder | NA | Status: COMPLETED